I begge undersøgelser tilbragte de patienter, der fik AZILECT som tillægsbehandling, ca. en time mindre i "off- tilstand" end de, der fik placebo.
In both studies, patients adding AZILECT spent an average of around one hour less in the ‘ off’ state than those adding placebo.